Burcon NutraScience Corporation Logo

Burcon NutraScience Corporation

BRCNF

(1.2)
Stock Price

0,05 USD

-79.37% ROA

-185.21% ROE

-2.74x PER

Market Cap.

20.253.377,72 USD

187.9% DER

0% Yield

-1758.62% NPM

Burcon NutraScience Corporation Stock Analysis

Burcon NutraScience Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Burcon NutraScience Corporation Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.53x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

4 ROE

Negative ROE (-31.8%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-46.89%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Burcon NutraScience Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Burcon NutraScience Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Burcon NutraScience Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Burcon NutraScience Corporation Revenue
Year Revenue Growth
1999 0
2000 1 100%
2001 2 50%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 30.309 100%
2014 94.724 68%
2015 105.387 10.12%
2016 106.390 0.94%
2017 87.839 -21.12%
2018 49.014 -79.21%
2019 40.177 -22%
2020 31.134 -29.05%
2021 258.646 87.96%
2022 171.471 -50.84%
2023 362.152 52.65%
2023 363.913 0.48%
2024 184.359 -97.39%
2025 946.468 80.52%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Burcon NutraScience Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1999 0
2000 206.431 100%
2001 931.396 77.84%
2002 2.199.577 57.66%
2003 1.956.045 -12.45%
2004 1.330.711 -46.99%
2005 1.406.035 5.36%
2006 1.301.739 -8.01%
2007 1.655.199 21.35%
2008 2.157.617 23.29%
2009 2.090.775 -3.2%
2010 2.189.237 4.5%
2011 2.889.853 24.24%
2012 1.040.085 -177.85%
2013 2.102.928 50.54%
2014 2.393.649 12.15%
2015 2.535.761 5.6%
2016 1.996.477 -27.01%
2017 1.875.745 -6.44%
2018 1.790.524 -4.76%
2019 1.594.180 -12.32%
2020 707.179 -125.43%
2021 188.825 -274.52%
2022 1.609.578 88.27%
2023 3.425.200 53.01%
2023 3.494.900 1.99%
2024 4.032.605 13.33%
2025 2.313.168 -74.33%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Burcon NutraScience Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1999 0
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 8.767.154 100%
2012 5.057.498 -73.35%
2013 3.555.242 -42.25%
2014 3.950.908 10.01%
2015 2.209.299 -78.83%
2016 2.331.823 5.25%
2017 2.196.508 -6.16%
2018 2.001.907 -9.72%
2019 1.491.905 -34.18%
2020 2.095.404 28.8%
2021 3.582.878 41.52%
2022 4.197.951 14.65%
2023 5.213.472 19.48%
2023 3.732.562 -39.68%
2024 3.624.577 -2.98%
2025 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Burcon NutraScience Corporation EBITDA
Year EBITDA Growth
1999 -11.861
2000 -448.055 97.35%
2001 -1.713.667 73.85%
2002 -3.136.177 45.36%
2003 -3.021.410 -3.8%
2004 -2.232.464 -35.34%
2005 -2.907.130 23.21%
2006 -2.667.827 -8.97%
2007 -3.490.376 23.57%
2008 -4.077.695 14.4%
2009 -4.719.410 13.6%
2010 -6.912.758 31.73%
2011 -8.767.154 21.15%
2012 -6.000.447 -46.11%
2013 -5.087.730 -17.94%
2014 -5.568.756 8.64%
2015 -6.014.112 7.41%
2016 -5.775.220 -4.14%
2017 -5.344.780 -8.05%
2018 -5.480.880 2.48%
2019 -4.261.950 -28.6%
2020 -3.596.920 -18.49%
2021 -4.299.020 16.33%
2022 -7.083.910 39.31%
2023 -15.627.336 54.67%
2023 -7.031.240 -122.26%
2024 -6.739.698 -4.33%
2025 -6.359.000 -5.99%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Burcon NutraScience Corporation Gross Profit
Year Gross Profit Growth
1999 0
2000 19.706 100%
2001 90.513 78.23%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 30.309 100%
2014 94.724 68%
2015 -1.727.397 105.48%
2016 -1.496.546 -15.43%
2017 -1.275.282 -17.35%
2018 -1.690.240 24.55%
2019 -1.177.772 -43.51%
2020 -815.003 -44.51%
2021 -527.311 -54.56%
2022 171.471 407.52%
2023 362.152 52.65%
2023 363.913 0.48%
2024 -518.824 170.14%
2025 -595.904 12.93%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Burcon NutraScience Corporation Net Profit
Year Net Profit Growth
1999 -9.003
2000 -637.639 98.59%
2001 -2.064.638 69.12%
2002 -3.869.865 46.65%
2003 -3.439.371 -12.52%
2004 -2.596.054 -32.48%
2005 -3.153.294 17.67%
2006 -2.857.149 -10.37%
2007 -3.546.630 19.44%
2008 -4.042.376 12.26%
2009 -4.811.331 15.98%
2010 -6.989.116 31.16%
2011 -8.806.474 20.64%
2012 -5.962.342 -47.7%
2013 -5.545.522 -7.52%
2014 -5.961.545 6.98%
2015 -6.579.424 9.39%
2016 -6.569.776 -0.15%
2017 -5.776.337 -13.74%
2018 -5.622.785 -2.73%
2019 -4.777.377 -17.7%
2020 -4.633.494 -3.11%
2021 -617.492 -650.37%
2022 -10.258.407 93.98%
2023 -15.984.672 35.82%
2023 -25.364.250 36.98%
2024 -7.446.193 -240.63%
2025 -7.477.084 0.41%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Burcon NutraScience Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1999 0
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%
2025 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Burcon NutraScience Corporation Free Cashflow
Year Free Cashflow Growth
1999 -5.560
2000 -568.155 99.02%
2001 -2.032.952 72.05%
2002 -4.457.200 54.39%
2003 -3.397.445 -31.19%
2004 -2.190.512 -55.1%
2005 -2.596.875 15.65%
2006 -1.936.543 -34.1%
2007 -2.524.141 23.28%
2008 -2.782.058 9.27%
2009 -3.034.081 8.31%
2010 -4.093.158 25.87%
2011 -3.810.673 -7.41%
2012 -5.960.064 36.06%
2013 -5.099.127 -16.88%
2014 -5.206.986 2.07%
2015 -4.868.675 -6.95%
2016 -4.943.400 1.51%
2017 -4.764.366 -3.76%
2018 -4.644.013 -2.59%
2019 -4.165.501 -11.49%
2020 -4.306.496 3.27%
2021 -5.749.721 25.1%
2022 -7.145.365 19.53%
2023 -6.342.993 -12.65%
2023 -2.178.967 -191.1%
2024 -5.904.101 63.09%
2025 -1.990.202 -196.66%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Burcon NutraScience Corporation Operating Cashflow
Year Operating Cashflow Growth
1999 -5.560
2000 -499.967 98.89%
2001 -1.428.589 65%
2002 -2.953.255 51.63%
2003 -3.004.259 1.7%
2004 -2.127.843 -41.19%
2005 -2.432.306 12.52%
2006 -1.875.230 -29.71%
2007 -2.371.572 20.93%
2008 -2.717.391 12.73%
2009 -2.983.011 8.9%
2010 -3.804.655 21.6%
2011 -3.630.065 -4.81%
2012 -4.369.632 16.93%
2013 -4.768.068 8.36%
2014 -4.952.221 3.72%
2015 -4.819.743 -2.75%
2016 -4.883.575 1.31%
2017 -4.607.237 -6%
2018 -4.623.932 0.36%
2019 -4.146.946 -11.5%
2020 -2.738.233 -51.45%
2021 -2.876.975 4.82%
2022 -5.876.764 51.04%
2023 -5.983.087 1.78%
2023 -2.171.200 -175.57%
2024 -5.776.987 62.42%
2025 -1.815.370 -218.23%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Burcon NutraScience Corporation Capital Expenditure
Year Capital Expenditure Growth
1999 0
2000 68.188 100%
2001 604.363 88.72%
2002 1.503.945 59.81%
2003 393.186 -282.5%
2004 62.669 -527.4%
2005 164.569 61.92%
2006 61.313 -168.41%
2007 152.569 59.81%
2008 64.667 -135.93%
2009 51.070 -26.62%
2010 288.503 82.3%
2011 180.608 -59.74%
2012 1.590.432 88.64%
2013 331.059 -380.41%
2014 254.765 -29.95%
2015 48.932 -420.65%
2016 59.825 18.21%
2017 157.129 61.93%
2018 20.081 -682.48%
2019 18.555 -8.22%
2020 1.568.263 98.82%
2021 2.872.746 45.41%
2022 1.268.601 -126.45%
2023 359.906 -252.48%
2023 7.767 -4533.78%
2024 127.114 93.89%
2025 174.832 27.29%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Burcon NutraScience Corporation Equity
Year Equity Growth
1999 465.692
2000 5.308.019 91.23%
2001 6.075.410 12.63%
2002 3.936.651 -54.33%
2003 3.792.532 -3.8%
2004 6.040.307 37.21%
2005 3.465.899 -74.28%
2006 4.642.514 25.34%
2007 8.122.342 42.84%
2008 6.222.621 -30.53%
2009 3.950.642 -57.51%
2010 15.719.941 74.87%
2011 12.905.245 -21.81%
2012 9.386.790 -37.48%
2013 9.745.920 3.68%
2014 4.323.015 -125.44%
2015 5.791.886 25.36%
2016 4.112.221 -40.85%
2017 4.113.705 0.04%
2018 2.345.016 -75.42%
2019 -1.980.094 218.43%
2020 22.945.723 108.63%
2021 36.272.999 36.74%
2022 28.247.240 -28.41%
2023 24.521.021 -15.2%
2023 4.137.311 -492.68%
2024 5.153.499 19.72%
2025 3.488.727 -47.72%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Burcon NutraScience Corporation Assets
Year Assets Growth
1999 479.332
2000 5.380.702 91.09%
2001 6.362.871 15.44%
2002 4.211.704 -51.08%
2003 4.029.633 -4.52%
2004 6.318.725 36.23%
2005 3.645.428 -73.33%
2006 4.844.097 24.74%
2007 8.417.889 42.45%
2008 6.438.949 -30.73%
2009 4.297.372 -49.83%
2010 16.121.120 73.34%
2011 14.234.165 -13.26%
2012 10.526.098 -35.23%
2013 10.514.400 -0.11%
2014 5.122.686 -105.25%
2015 6.700.270 23.55%
2016 4.853.066 -38.06%
2017 6.793.370 28.56%
2018 5.438.983 -24.9%
2019 2.463.436 -120.79%
2020 31.269.212 92.12%
2021 37.724.745 17.11%
2022 29.349.737 -28.54%
2023 25.382.354 -15.63%
2023 9.899.369 -156.4%
2024 12.912.571 23.34%
2025 10.582.095 -22.02%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Burcon NutraScience Corporation Liabilities
Year Liabilities Growth
1999 13.640
2000 72.683 81.23%
2001 287.461 74.72%
2002 275.053 -4.51%
2003 237.101 -16.01%
2004 278.418 14.84%
2005 179.529 -55.08%
2006 201.583 10.94%
2007 295.547 31.79%
2008 216.328 -36.62%
2009 346.730 37.61%
2010 401.179 13.57%
2011 1.328.920 69.81%
2012 1.139.308 -16.64%
2013 768.480 -48.25%
2014 799.671 3.9%
2015 908.384 11.97%
2016 740.845 -22.61%
2017 2.679.665 72.35%
2018 3.093.967 13.39%
2019 4.443.530 30.37%
2020 8.323.489 46.61%
2021 1.451.746 -473.34%
2022 1.102.497 -31.68%
2023 861.333 -28%
2023 5.762.058 85.05%
2024 7.759.072 25.74%
2025 7.093.368 -9.38%

Burcon NutraScience Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.05
Price to Earning Ratio
-2.74x
Price To Sales Ratio
48.11x
POCF Ratio
-3.21
PFCF Ratio
-3.08
Price to Book Ratio
5.81
EV to Sales
58.54
EV Over EBITDA
-3.65
EV to Operating CashFlow
-3.91
EV to FreeCashFlow
-3.74
Earnings Yield
-0.37
FreeCashFlow Yield
-0.33
Market Cap
0,02 Bil.
Enterprise Value
0,02 Bil.
Graham Number
0.17
Graham NetNet
-0.03

Income Statement Metrics

Net Income per Share
-0.05
Income Quality
0.85
ROE
-1.85
Return On Assets
-0.7
Return On Capital Employed
-0.74
Net Income per EBT
1
EBT Per Ebit
0.99
Ebit per Revenue
-17.73
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
6.63
Research & Developement to Revenue
7.97
Stock Based Compensation to Revenue
1.41
Gross Profit Margin
-0.4
Operating Profit Margin
-17.73
Pretax Profit Margin
-17.59
Net Profit Margin
-17.59

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.04
Free CashFlow per Share
-0.05
Capex to Operating CashFlow
-0.04
Capex to Revenue
0.66
Capex to Depreciation
0.39
Return on Invested Capital
-0.75
Return on Tangible Assets
-0.79
Days Sales Outstanding
355.36
Days Payables Outstanding
257.9
Days of Inventory on Hand
15.06
Receivables Turnover
1.03
Payables Turnover
1.42
Inventory Turnover
24.23
Capex per Share
0

Balance Sheet

Cash per Share
0,02
Book Value per Share
0,02
Tangible Book Value per Share
0.02
Shareholders Equity per Share
0.02
Interest Debt per Share
0.05
Debt to Equity
1.88
Debt to Assets
0.62
Net Debt to EBITDA
-0.65
Current Ratio
5.63
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
4768299
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.12
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
49869
Debt to Market Cap
0.32

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Burcon NutraScience Corporation Dividends
Year Dividends Growth

Burcon NutraScience Corporation Profile

About Burcon NutraScience Corporation

Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company's products include Peazazz, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products; and Peazac and Peazac 850, a pea protein for plant-based meat alternative products, ready-to-mix powders, ready-to-mix beverages, dairy alternatives, and nutrition bars, as well as other applications requiring the most neutral flavor and moderate viscosity. It provides Puratein, a canola protein isolate for use in meat alternatives, such as burgers, sausages, and nutrition bars; Supertein, a canola protein that is a light-colored powder for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows and ready-to-mix beverages, whipped toppings, and plant-based bars; and Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods. In addition, the company offers Nutratein-PS and Nutratein-TZ, a blend of Peazac pea protein; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and other foods and nutritional products. Further, it provides MeritPro, a nutritional protein blend, including allergen-free, gluten-free, non-dairy, non-GMO, and vegan. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. The company was incorporated in 1998 and is headquartered in Vancouver, Canada.

CEO
Mr. Kip Underwood M.B.A.
Employee
25
Address
1946 West Broadway
Vancouver, V6J 1Z2

Burcon NutraScience Corporation Executives & BODs

Burcon NutraScience Corporation Executives & BODs
# Name Age
1 Ms. Kam T. Law
Senior Vice President of Legal & Corporate Secretary
70
2 Mr. Randy Willardsen
Senior Vice President of Process
70
3 Mr. Robert Peets C.F.A., M.B.A.
Chief Financial Officer
70
4 Mr. Paul Lam
Director of Investor Relations
70
5 Dr. Martin Hans Schweizer Ph.D.
Vice President of Technical Development
70
6 Mr. Kip Underwood M.B.A.
Chief Executive Officer
70

Burcon NutraScience Corporation Competitors